Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
December 23rd 2024In the second part of a three-part interview from the recent RSNA conference, Mark Traill, M.D., emphasizes patience and monitoring with the assessment of AI to ensure optimal use of the technology to help ease the strain of increasing breast imaging volume.
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 1
December 19th 2024In the first of a three-part interview from the recent RSNA conference, Mark Traill, M.D., discusses current challenges in breast radiology and the potential of AI to help mitigate some of these issues.
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
December 5th 2024In a recent interview, Sarah Friedewald, MD, discussed new study findings for an adjunctive AI software for digital breast tomosynthesis (DBT) that revealed nearly equivalent sensitivity and specificity rates for breast cancer across a diverse cohort.
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
December 4th 2024In a recent interview at the RSNA conference, Shadpour Demehri, MD and Kamyar Moradi, MD discussed new brain MRI research findings that demonstrated a link between increased dementia risk and sarcopenia with the temporalis muscle.
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
November 15th 2024In an interview, SNMMI president Cathy Cutler, PhD, discussed the impact of the recent CMS decision to unbundle reimbursement for diagnostic radiopharmaceuticals costing above $630 a day, calling it a “game changer” decision that will benefit patients, physicians, and the development of new radiopharmaceutical agents.
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
November 1st 2024In a recent interview, Stamatia Destounis, M.D., discussed the impact of national breast density notification for mammography reports and key considerations with staffing and ongoing education for patients, staff and referring providers on the merits of supplemental breast imaging.
Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams
September 25th 2024Key opinion leaders explore the significance of interdisciplinary collaboration in prostate cancer management, with a focus on how PSMA PET imaging enhances decision-making processes within multidisciplinary care teams.
Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging
September 11th 2024Key opinion leaders examine the role of advanced imaging agents, particularly PSMA PET and other radiotracers, in identifying and defining oligometastatic disease in patients with prostate cancer.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
August 13th 2024In a recent interview, Soroush Rais-Bahrami, M.D., discussed key findings from a post-hoc subgroup analysis of the SPOTLIGHT trial that examined the use of the PET imaging agent 18F-flotufolastat (Posluma) in African American men.
Could Pluvicto Have a Role in Taxane-Naive mCRPC?: an Interview with Oliver Sartor, MD
June 10th 2024In an interview at the SNMMI 2024 conference, Oliver Sartor, M.D. discussed key findings from new award-winning research evaluating the potential of Pluvicto in treating patients with taxane-naïve metastatic castration-resistant prostate cancer (mCRPC).
New SNMMI President Cathy Cutler, PhD Discusses Current Challenges and Goals for Nuclear Medicine
June 9th 2024In a recent interview, Cathy Cutler, Ph.D., shared her perspective on a number of topics affecting nuclear medicine, ranging from isotope availability and reimbursement challenges for diagnostic radiopharmaceuticals to increasing patient interest in PET imaging.
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
April 30th 2024In a recent interview, Steven Raman, M.D., discussed the use of MRI-guided transurethral ultrasound (TULSA) in the treatment of intermediate risk prostate cancer and key research findings with one- and five-year outcomes.
Improving the Quality of Breast MRI Acquisition and Processing
April 12th 2024Discussing findings from a new study presented at the Society for Breast Imaging (SBI) conference, Shahrzad Tavana, M.D., detailed the significant impact of training sessions for MRI technologists in improving breast positioning, optimal field of view and accuracy of sequence submissions to PACS for breast MRI exams.